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E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 37phase centrosomes and thereby negatively regulates entry into
mitosis by preventing premature activation of cyclin B-Cdk1
[Nat Cell Biol 2004;6:884–91].
Methods: In synchronized U2OS cells, we inhibited Chk1 kinase
by the specific inhibitor CEP-3891 and manipulated this system
using different constructs and siRNAs.
Results: Chk1 inhibition induced premature mitotic entry dis-
playing regular spindles but deficient chromatin condensation –
which we have termed the ‘paraspindle’ phenotype –, apparently
resulting in mitotic nuclear fragmentation. The paraspindle phe-
notype was reverted by inhibition of the Cdc25B phosphatase
using siRNA, which restored normal mitoses with regular chro-
mosome condensation.
Conclusion: Cdc25B is an important downstream target of Chk1
in the regulation of mitotic entry. Our data may help elucidate the
mechanism of genomic instability as an early step in
carcinogenesis.
doi:10.1016/j.ejcsup.2006.04.087
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Background: Calpains are a family of 14 known intracellular cal-
cium dependent cysteine proteases that share a similar catalytic
structure. Calpains are involved in several key aspects of migra-
tion, including: adhesion and spreading; detachment of the rear;
and membrane protrusion. The best described calpains are l and
M calpain which are ubiquitous heterodimeric proteins composed
of a distinct catalytic subunit and a common regulatory subunit
called regulatory calpain (CSS1). Studies have shown the impor-
tance of CSS1 for the function of both l and M calpains. So far
there is not much known about the promoter and transcriptional
regulation of this important gene, therefore we conducted the fol-
lowing study to characterize the promoter and major cis acting
elements in the 5 0 prime region of CSS1 gene.
Methods: Different CSS1 promoter regions spanning 2.0 kb 5 0
upstream and 1.0 kb downstream region from the transcription
start site were PCR amplified using Hela cell genomic DNA, cloned
into pGEMT-Easy cloning vector, and sequenced. Luciferase repor-
ter constructs were made by subcloning these fragments into
pGL3-Basic vector. Luciferase assay was carried out in Hela,
MCF7 and HCT116 cell lines. EMSA and supershift with specific
antibodies was done using the standard protocol. TRANSFAC
database was used to scan the sequence for putative transcrip-
tion factor binding sites.
Results: All the three cell lines tested showed high constitute
expression of CSS1 mRNA and showed more or less similar pat-
tern of promoter activity for different deletion constructs of
CSS1, with construct 121 to +274 showing the highest activity.
Region 55 to 25 seems to be important for the core promoteractivity, this region contains a putative NRF1 biding site. NRF1
was found to bind to this region in EMSA. Interestingly, deletion
construct 55 to 2 which has lost the first noncoding exonic
region showed complete lack of promoter activity, suggesting that
the first noncoding exon containing putative AP-1-and Ets-1-
binding sites is required for basal promoter activity. Binding of
AP-1-transcription factors to this exonic region has already been
confirmed in gelshift analysis.
Conclusion: This study describes for the first time the minimal
region required for the basal activity of CSS1 promoter and defines
cis-elements and transcription factors regulating this vital gene.
doi:10.1016/j.ejcsup.2006.04.088
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Background: Circulating cell detection using RT-PCR techniques
has been studied as new prognostic factor in prostatic cancer
patients. To enhance detection sensitivity of these techniques,
we have developed a new multiplex RT-PCR assay for prostate cir-
culating cell detection based on the combined expression of KLK3
(formerly PSA), FOLH1 (formerly PSAM), PSCA, KLK2 and KLK15
(formerly prostinogen).
Methods: Our approach associate classical RT-PCR technics,
fluorescent labelling and a very sensitive capillary electrophoresis
detection. After RT-PCR, PCR products are visualized using capil-
lary electrophoresis and fluorescent detection which is very reli-
able to indicate the precise size of the detected fluorescent
products. We first test our new detection technique using prostate
cancer cell lines known to express all of these genes and
improved its sensibility using serial dilution of these cells in
healthy blood samples: the limit of detection was found to be as
few as 1 expressing cell in 106 nucleated blood cells. Between July
2005 and January 2006, 41 prostate cancer patients, 12 non pros-
tate cancer patients and 11 healthy individuals were included
and this multiplex RT-PCR assay was used to detect prostate cir-
culating cells.
Results: Multiplex RT-PCR assay was positive in 13/41 (32%) of
the prostate cancer patients for 3 of the 5 markers, whereas 4/
41 (10%) were found positive for 5 markers. The test was negative
for the 23 non prostate cancer patients or healthy individuals.
Conclusion: This multiplex RT-PCR assay with five markers
proved to be more sensitive than a single one in detecting prostate
circulating tumor cells. The discrepant expression of KLK3, FOLH1,
PSCA, KLK2 or KLK15 may label circulating tumor cells with differ-
ent levels of differentiation and subsequent aggressive behaviour,
and increases the capability to detect prostate circulating cells.
doi:10.1016/j.ejcsup.2006.04.089
